SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,139.47 |
| Enterprise Value ($M) | 1,751.03 |
| Book Value ($M) | 195.43 |
| Book Value / Share | 5.98 |
| Price / Book | 5.83 |
| NCAV ($M) | -410.28 |
| NCAV / Share | -12.54 |
| Price / NCAV | -2.78 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.05 |
| Return on Assets (ROA) | 0.04 |
| Return on Equity (ROE) | 0.27 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.85 |
| Current Ratio | 1.96 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 537.60 |
| Assets | 1,143.31 |
| Liabilities | 947.88 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 566.77 |
| Operating Income | 166.96 |
| Net Income | 48.16 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 274.75 |
| Cash from Investing | -70.81 |
| Cash from Financing | -140.18 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Eventide Asset Management, Llc | 8.07 | 0.03 | |
| 13G/A | Vanguard Group Inc | 7.09 | 4.74 | |
| 13G/A | Rubric Capital Management LP | 8.46 | -17.26 | |
| 13G/A | BlackRock Inc. | 17.70 | 0.96 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES | ||
| UNITED STATES | ||
| UNITED STATES | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 28,117 | 247,432 | 11.36 | |
| 50,128 | 154,110 | 32.53 | |
| 14,795 | 98,288 | 15.05 | |
| 38,876 | 256,530 | 15.15 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CGEM – Cullinan Therapeutics, Inc. | CGON – CG Oncology, Inc. |
| COGT – Cogent Biosciences, Inc. | CPIX – Cumberland Pharmaceuticals Inc. |
| CRBU – Caribou Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io